The University of Southampton
University of Southampton Institutional Repository

Hughes syndrome (the antiphospholipid syndrome): 25 years old

Hughes syndrome (the antiphospholipid syndrome): 25 years old
Hughes syndrome (the antiphospholipid syndrome): 25 years old
The antiphospholipid (Hughes) syndrome (APS) is a unique thrombotic disorder, causing both arterial and venous thrombosis, linked to the presence of antibodies directed against phospholipid–protein complexes. The first papers describing the syndrome were published in 1983 and, over the next two years, a series of publications described in detail the various clinical manifestations of the syndrome. Laboratory standardisation workshops were also set up and, in 1984, the first “world” symposium on APS was held. The international APS conferences have continued to grow in numbers and in stature. The APS has already had an impact in obstetrics, in medicine, in psychiatry, and in surgery. The approximate figure of 1 in 5 is a useful guide—1 in 5 of all young strokes, 1 in 5 recurrent miscarriages, 1 in 5 DVTs. More precise data will become available in the worlds of epilepsy, migraine, Alzheimer’s, and MS. The advent of newer “biologic” immunosuppressives such as rituximab may offer help in selected cases. Intravenous immunoglobulin has proved successful, especially in the emergency setting.
syndrome, antiphospholipid syndrome
119-124
Edwards, C.J.
dcb27fec-75ea-4575-a844-3588bcf14106
Hughes, G.R.V.
08b534e9-8352-49fb-9d62-b1ed88e15134
Edwards, C.J.
dcb27fec-75ea-4575-a844-3588bcf14106
Hughes, G.R.V.
08b534e9-8352-49fb-9d62-b1ed88e15134

Edwards, C.J. and Hughes, G.R.V. (2008) Hughes syndrome (the antiphospholipid syndrome): 25 years old. Modern Rheumatology, 18 (2), 119-124. (doi:10.1007/s10165-008-0042-3).

Record type: Article

Abstract

The antiphospholipid (Hughes) syndrome (APS) is a unique thrombotic disorder, causing both arterial and venous thrombosis, linked to the presence of antibodies directed against phospholipid–protein complexes. The first papers describing the syndrome were published in 1983 and, over the next two years, a series of publications described in detail the various clinical manifestations of the syndrome. Laboratory standardisation workshops were also set up and, in 1984, the first “world” symposium on APS was held. The international APS conferences have continued to grow in numbers and in stature. The APS has already had an impact in obstetrics, in medicine, in psychiatry, and in surgery. The approximate figure of 1 in 5 is a useful guide—1 in 5 of all young strokes, 1 in 5 recurrent miscarriages, 1 in 5 DVTs. More precise data will become available in the worlds of epilepsy, migraine, Alzheimer’s, and MS. The advent of newer “biologic” immunosuppressives such as rituximab may offer help in selected cases. Intravenous immunoglobulin has proved successful, especially in the emergency setting.

This record has no associated files available for download.

More information

Published date: April 2008
Keywords: syndrome, antiphospholipid syndrome

Identifiers

Local EPrints ID: 70365
URI: http://eprints.soton.ac.uk/id/eprint/70365
PURE UUID: f5702008-5755-47ff-a945-d209535191d5

Catalogue record

Date deposited: 10 Feb 2010
Last modified: 13 Mar 2024 20:03

Export record

Altmetrics

Contributors

Author: C.J. Edwards
Author: G.R.V. Hughes

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×